Which former NC Vermont News area high school standouts will be in action on Friday, April 18?

Shane Starr and Trevor Arsenault -
Shane Starr and Trevor Arsenault -
0Comments

These former NC Vermont News area high school standouts will be in action on Friday, April 18.

Shane Starr and Trevor Arsenault -
Ben Alekson
Fairfield Stags
Right handed pitcher
Sophomore
6′2″ 200
Stowe High School
Hometown: Stowe
Next Game: vs. Merrimack Warriors, Friday, April 18, 1 p.m.

Shane Starr and Trevor Arsenault -
Nate Groff
Beloit Buccaneers
Freshman
Montpelier High School
Hometown: Montpelier
Next Game: vs. Grinnell Pioneers, Friday, April 18, 1 p.m.

Shane Starr and Trevor Arsenault -
Shane Starr
Franklin Pierce Ravens
Outfielder
Freshman
6′0″ 190
U-32 High School (uhsd #32)
Hometown: Moretown
Next Game: vs. Assumption Greyhounds, Friday, April 18, 12 p.m.

Shane Starr and Trevor Arsenault -
Trevor Arsenault
Saint Michael’s Purple Knights
Shortstop
Sophomore
5′9″ 170
Spaulding High School
Hometown: Websterville
Next Game: vs. SNHU Penmen, Friday, April 18, 12 p.m.



Related

Lisa Hango, Vermont State Representative for the Franklin-5 District

Vermont lawmaker discusses legislative session delays and bill volume concerns

Vermont State Representative Lisa Hango reports continued delays at an extended legislative session as key budget-related bills remain unresolved. Hango highlights concerns about high bill volume and associated costs while discussing recent committee actions.

Sara Brenner, Principal Deputy Commissioner at FDA

FDA conducted inspection of 1 company in cities located in Washington County in 2025

There was one company in a city associated with Washington County that received an FDA inspection in 2025, according to the U.S. Food and Drug Administration.

Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs of FDA

1 company in a city within Lamoille County received one inspection in 2025

There was one company in a city associated with Lamoille County that received an FDA inspection in 2025, according to the U.S. Food and Drug Administration.